CBD-Intel offers a review of the science behind some of cannabis’s lesser-known compounds – the so-called “minor cannabinoids” – with an emphasis on their potential applications ...
CBD-Intel podcast editor Jon Bruford discusses packaging design with Steve Wilkins, senior project manager of Duallok, US manufacturers of child-resistant packaging systems ...
It does not look like good news. The only two companies (controlling three brands that contain 23 individually listed products) included in the initial list of validated applications both say they submitted their applications to...
A new deputy commissioner at the US Food and Drug Administration (FDA) will likely be the single person with the most influence on the path to market for CBD in the US ...
Canadian cannabis firm Tilray is moving in on New Zealand’s market for medical cannabis and has received the necessary approvals to launch Tilray medical cannabis products across the country ...
Suggestions that a Chinese ban on the use of CBD in cosmetics that would essentially shut down the domestic CBD market, blocking imports and cross-border online sales, appear to be premature ...
From a consumer/market perspective, it certainly looks like delta-8 THC is the most promising minor cannabinoid. It has quickly overtaken others such as CBG and CBN in terms of general awareness and – anecdotally – in terms of...
Four new letters sent by the US Food and Drug Administration (FDA) in the month of April mark a bit of a change in approach. Two of them were fairly standard warnings about health claim...
Germany’s highest civil and criminal court has ruled that low-THC industrial hemp flowers may be considered a narcotic – but that they can be legally sold to German consumers if there is no risk of...
The FSA told CBD-Intel during a recent conference that – unsurprisingly – no actions would be taken until after the list of validated/administratively checked pending validation applications had been published. Thus far no date for the...
A lab technician’s slip-up five decades ago could cause a complete rethink of cannabis and CBD regulation in many jurisdictions, legal scholars warned today ...
An Oregon senator believes he has found a solution to the cannabis banking crisis in the state, and perhaps set a useful standard for others across the US ...
What regulations apply to CBD around the world, how are they set to change, and what impact will the changes have on the cannabidiol sector? A presentation by CBD-Intel head of legal analysis, Pablo Cano...
The UK Food Standards Agency (FSA) has ruffled a few feathers by changing its criteria for allowing products to stay on the market. Instead of requiring a validated novel food submission, it now only requires...
Podcasts editor Jon Bruford is joined by Anthony Traurig, CBD-Intel legal analyst and US specialist, to discuss the legal and regulatory concerns that hang over cannabis in the US and Canada and the economic impact...
A drop in the cost of bulk CBD has not yet been wholly reflected in falling CBD product prices – but are we about to witness a perfect storm for a race to the...
Companies now only to have submitted an application to the UK Food Standards Agency (FSA) in order for their edible CBD products to stay on the market after 1st April ...
Swiss consumers are head-for-head the biggest purchasers of CBD products, according to CBD-Intel’s 2021 market size analysis. Meanwhile, we predict big growth in a number of other markets, and a shift in the most popular...
Sign up to access our business and regulatory briefings and get the most updated news, insights and our expert analysis to keep you on top of worldwide industry trends.